Jones Trading is a financial services company based out of 28 Deer St, Portsmouth, New Hampshire, United States.
Location: United States, North Carolina
Employees: 51-200
Founded date: 1975
Investors 1
| Date | Name | Website |
| - | FFL Partne... | fflpartner... |
Mentions in press and media 7
| Date | Title | Description |
| 10.04.2026 | Software rout deepens as AI fears grip investors | US software shares tumbled on Thursday as fears over disruptions from advances in AI returned to the forefront following a recent update from Anthropic. Investors have dumped the sector’s stocks this year on worries that AI tools that are c... |
| 13.02.2026 | Analysis:For stock market, AI turns from lifting all boats to sinking ships | NEW YORK, Feb 12 : Investors are discovering that the artificial intelligence landscape is not just fertile ground for stocks - it is also a minefield. Enthusiasm about AI's profitability has fueled the U.S. bull market, with stock gains fo... |
| 18.11.2025 | Bitcoin briefly falls below $90,000 to lowest since April | Bitcoin wavered as investors continued to shed their speculative technology holdings with the cryptocurrency first among them. Bitcoin was last trading up 1.6% at $93,236.00, but earlier Tuesday touched $89,259, its lowest since April 22. B... |
| 27.08.2025 | Cereno Scientific Publishes Interim Report for Q2 2025 (April 1 – June 30, 2025) | Cereno Scientific Publishes Interim Report for Q2 2025 (April 1 – June 30, 2025) Wed, Aug 27, 2025 08:00 CET Report this content Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and exte... |
| 29.07.2024 | All eyes on Big Tech this week | The Microsoft logo outside Microsoft South Africa’s head office in Johannesburg The violent rotation out of Big Tech has dragged the Nasdaq 100 Index down 8% in just over two weeks, leaving it on the cusp of a correction. Whether it can avo... |
| 04.04.2024 | JonesTrading welcomes Hans Vitzthum as Managing Director, Business Development | JonesTrading is pleased to announce the appointment of Hans Vitzthum as Managing Director, Business Development Mr. Vitzthum brings decades of experience to the role spanning institutional sales, equity research management, capital markets,... |
| 10.02.2022 | Aeglea BioTherapeutics Announces Proposed Public Offering | AUSTIN, Texas, Feb. 9, 2022 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (Nasdaq:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare metabolic diseases, tod... |